Top Markets
Coin of the day
Hualan Biological Engineering Inc. Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc.

002007
株式のランク #4590
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
株価
$1.92
時価総額
$3.51B
変化(1日)
1.07%
変化(1年)
-22.38%
CN
取引 Hualan Biological Engineering Inc. (002007)

カテゴリー

Hualan Biological Engineering Inc.(002007)の株式分割履歴
Hualan Biological Engineering Inc.株(シンボル:002007)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 26, 2026に行われました。
Aug 26, 2026より前に購入された002007株は、現在0002007株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH